Schizophrenia
|
0.320 |
Biomarker
|
disease |
BEFREE |
Thus, this study did not provide evidence for the contribution of the mGluR4 gene to schizophrenia in the Japanese.
|
11525421 |
2001 |
Schizophrenia
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Thus, this study did not provide evidence for the contribution of the mGluR4 gene to schizophrenia in the Japanese.
|
11525421 |
2001 |
Juvenile Myoclonic Epilepsy
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
The mGluR4 gene also falls within a susceptibility locus for juvenile myoclonic epilepsy suggesting a potential link to this form of epilepsy.
|
11223165 |
2001 |
Epilepsy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Localization of the human mGluR4 gene within an epilepsy susceptibility locus(1).
|
11223165 |
2001 |
Seizures
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Disruption of the mGluR4 gene in mice results in impaired motor and spatial learning, and alterations in seizure susceptibility.
|
11223165 |
2001 |
Juvenile Myoclonic Epilepsy
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Our results provide no evidence that genetic variation of the GRM4 gene confers susceptibility to JME-related IGE syndromes.
|
14582146 |
2003 |
Idiopathic generalized epilepsy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Our results provide no evidence that genetic variation of the GRM4 gene confers susceptibility to JME-related IGE syndromes.
|
14582146 |
2003 |
Colonic Neoplasms
|
0.010 |
Biomarker
|
group |
LHGDN |
Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line.
|
15217955 |
2004 |
Bipolar Disorder
|
0.300 |
Biomarker
|
disease |
PSYGENET |
Six genes (DAO, GRM3, GRM4, GRIN2B, IL2RB, and TUBA8) met this criterion for bipolar I disorder; only DAO has been previously associated with bipolar disorder.
|
16380905 |
2005 |
Epilepsy, Temporal Lobe
|
0.300 |
Biomarker
|
disease |
CTD_human |
Here, we examine the transcription levels of mGluRs class I (mGluR1 and 5) and III (mGluR4 and 7) in experimental TLE and correlate differential mGluR subunit expression with mouse-strain-dependent susceptibility to TLE induced by pilocarpine.
|
15694259 |
2005 |
Uncinate Epilepsy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression analysis of metabotropic glutamate receptors I and III in mouse strains with different susceptibility to experimental temporal lobe epilepsy.
|
15694259 |
2005 |
Epilepsy, Benign Psychomotor, Childhood
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression analysis of metabotropic glutamate receptors I and III in mouse strains with different susceptibility to experimental temporal lobe epilepsy.
|
15694259 |
2005 |
Epilepsy, Lateral Temporal
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression analysis of metabotropic glutamate receptors I and III in mouse strains with different susceptibility to experimental temporal lobe epilepsy.
|
15694259 |
2005 |
Mitral Valve Stenosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
No mGluR4 IR was detected in cells of the microglia/macrophage lineage in the MS lesions studied.
|
15589052 |
2005 |
Multiple Sclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
No mGluR4 IR was detected in cells of the microglia/macrophage lineage in the MS lesions studied.
|
15589052 |
2005 |
Medulloblastoma
|
0.020 |
Biomarker
|
disease |
LHGDN |
These data suggest that mGlu4 receptor enhancers are promising drugs for the treatment of medulloblastomas.
|
16899734 |
2006 |
Bipolar Disorder
|
0.300 |
Biomarker
|
disease |
PSYGENET |
Several candidate genes for schizophrenia may also be associated with bipolar disorder: G72, DISC1, NRG1, RGS4, NCAM1, DAO, GRM3, GRM4, GRIN2B, MLC1, SYNGR1, and SLC12A6.
|
17239033 |
2007 |
Nerve Degeneration
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy.
|
17446080 |
2007 |
Epilepsy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Presence of epilepsy, although rare in patients with 6p duplication may be linked to genes involved in brain function and synaptic transmission in the 6p21.2p22.1 duplicated region (GABBR1, BRD2 and GRM4).
|
18463015 |
2008 |
Schizophrenia
|
0.320 |
Biomarker
|
disease |
BEFREE |
We conclude that at least one susceptibility locus for schizophrenia is located within or nearby GRM7, whereas GRM4 is unlikely to be a major susceptibility gene for schizophrenia in the Japanese population.
|
19351574 |
2009 |
Schizophrenia
|
0.320 |
Biomarker
|
disease |
PSYGENET |
We conclude that at least one susceptibility locus for schizophrenia is located within or nearby GRM7, whereas GRM4 is unlikely to be a major susceptibility gene for schizophrenia in the Japanese population.
|
19351574 |
2009 |
Juvenile Myoclonic Epilepsy
|
0.040 |
Biomarker
|
disease |
BEFREE |
Nominally significant associations were detected between IGE and seven GRM4 SNPs (with P-values ranging from 0.037 to 0.0036), between JME and five SNPs (P=0.042-0.0106), and between CAE and two SNPs (P=0.0466-0.0021).
|
20338729 |
2010 |
Idiopathic generalized epilepsy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Association analysis was carried out for 17 single nucleotide polymorphisms (SNPs) covering the genomic GRM4 sequence for all IGE patients as well as for two common IGE subsyndromes [Juvenile Myoclonic Epilepsy (JME, n=215) and Childhood Absence Epilepsy (CAE, n=175)].
|
20338729 |
2010 |
Epilepsy, Generalized
|
0.010 |
Biomarker
|
disease |
BEFREE |
Role of GRM4 in idiopathic generalized epilepsies analysed by genetic association and sequence analysis.
|
20338729 |
2010 |
Absence Epilepsy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Association analysis was carried out for 17 single nucleotide polymorphisms (SNPs) covering the genomic GRM4 sequence for all IGE patients as well as for two common IGE subsyndromes [Juvenile Myoclonic Epilepsy (JME, n=215) and Childhood Absence Epilepsy (CAE, n=175)].
|
20338729 |
2010 |